Acso Australia

Acso Australia company information, Employees & Contact Information

Explore related pages

Related company profiles:

Our vision is for a community where everyone has the opportunity to thrive, and prison truly is the last resort. Our purpose is to strengthen the wellbeing of communities by advocating for and delivering services which divert people away from the justice system. Our ethos is 'Understand the story. Support the change.' Founded in 1984 on the lived experience of Stan McCormack, the Australian Community Support Organisation (ACSO) has delivered services to help break the cycle of people repeatedly entering the justice system because they lack the support to make change. ACSO works with people at risk of entering or who have already entered the justice system. Our work supports, diverts or reintegrates people through a range of services including mental health, alcohol and other drug treatment, intensive residential support, housing and employment. These services span the entire justice continuum from prevention to rehabilitation. We are collaborators. We understand the linkages of issues and policies and work to connect across government and industry to evolve services, improve equitable access to services and strengthen the evidence base to prevent people from becoming entrenched in the justice system. This will lead to better outcomes for communities across Australia, our clients and government partners. To learn more about our work, visit out website.
Looking for a particular Acso Australia employee's phone or email?

Acso Australia Questions

News

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice - ASCO Publications

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice ASCO Publications

Fertility Preservation in People With Cancer: ASCO Guideline Clinical Insights - ASCO Publications

Fertility Preservation in People With Cancer: ASCO Guideline Clinical Insights ASCO Publications

Patient Resources - American Society of Clinical Oncology - ASCO

Patient Resources American Society of Clinical Oncology - ASCO

MD Anderson at ASCO - MD Anderson Cancer Center

MD Anderson at ASCO MD Anderson Cancer Center

A Transnosographic Self-Assessment of Social Cognitive Impairments (ACSO): First Data - Frontiers

A Transnosographic Self-Assessment of Social Cognitive Impairments (ACSO): First Data Frontiers

Home - Ada County (.gov)

Home Ada County (.gov)

ASCO 2024: data on weight loss drugs and a melanoma vaccine, a test that can predict breast cancer relapse, and more - Cancer Research UK - Cancer News

ASCO 2024: data on weight loss drugs and a melanoma vaccine, a test that can predict breast cancer relapse, and more Cancer Research UK - Cancer News

Photovoltaic Properties and Long-Term Durability of Porphyrin-Sensitized Solar Cells with Silicon-Based Anchoring Groups - ACS Publications

Photovoltaic Properties and Long-Term Durability of Porphyrin-Sensitized Solar Cells with Silicon-Based Anchoring Groups ACS Publications

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update | Journal of Clinical Oncology - ASCO Publications

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update | Journal of Clinical Oncology ASCO Publications

High-Energy Nitramine Explosives: A Design Strategy from Linear to Cyclic to Caged Molecules - ACS Publications

High-Energy Nitramine Explosives: A Design Strategy from Linear to Cyclic to Caged Molecules ACS Publications

Antiemetics: ASCO Guideline Update - ASCO Publications

Antiemetics: ASCO Guideline Update ASCO Publications

Integrative Therapies in Cancer Care: An Update on the Guidelines - ASCO Publications

Integrative Therapies in Cancer Care: An Update on the Guidelines ASCO Publications

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study | Journal of Clinical Oncology - ASCO Publications

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study | Journal of Clinical Oncology ASCO Publications

ASCO-CAP Guideline Update Confirms Previous Recommendations for HER2 Testing in Breast Cancer - ASCO Daily News

ASCO-CAP Guideline Update Confirms Previous Recommendations for HER2 Testing in Breast Cancer ASCO Daily News

Top Acso Australia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant